Stewart Fisher - Apr 12, 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Chief Scientific Officer
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Apr 12, 2022
Transactions value $
$137,120
Form type
4
Date filed
4/12/2022, 08:41 PM
Previous filing
Feb 16, 2022
Next filing
May 27, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Options Exercise $8K +2.16K +4.98% $3.71 45.5K Apr 12, 2022 Direct
transaction CCCC Common Stock Options Exercise $129K +25.9K +57.03% $4.98 71.4K Apr 12, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -2.16K -5.71% $0.00 35.6K Apr 12, 2022 Common Stock 2.16K $3.71 Direct F1
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -25.9K -35% $0.00 48.2K Apr 12, 2022 Common Stock 25.9K $4.98 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 20% of this option vested and became exercisable on May 1, 2019, with the remainder vesting in 16 equal quarterly installments thereafter.
F2 This option vests and becomes exercisable in 20 equal quarterly installments, with the first installment vested on September 5, 2020.